Skip to main content
N

Nilocas

This medical device company develops a non-invasive patch that detects coronary artery disease by capturing sounds of turbulent blood flow in narrowed coronary arteries. This allows medical professionals to diagnose coronary heart disease without an angiogram, reducing costs and enabling earlier intervention.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Current methods for detecting coronary artery disease often rely on invasive procedures like angiograms, which are expensive and carry risks, or may miss early-stage disease. A significant percentage of patients undergoing angiograms are found not to have coronary heart disease, leading to unnecessary procedures and costs.

Solution

Nilocas is developing a non-invasive patch-based medical device for the detection of coronary artery disease. The device captures acoustic signals generated by turbulent blood flow in narrowed coronary arteries, indicative of stenosis. Microphones and accelerometers within the patch detect these disturbed flow patterns. The data is then analyzed using AI and machine learning algorithms to provide a result indicating the presence or absence of coronary artery disease. This technology aims to provide a cost-effective and accessible method for early detection and monitoring of coronary artery disease in various care settings, potentially reducing the need for invasive angiograms.

Target Audience

The primary target audience includes cardiologists, general practitioners, and other healthcare providers involved in the diagnosis and management of coronary artery disease, as well as patients at risk of or suspected of having the condition.

Features

  • Non-invasive patch design for easy application on the patient's chest
  • Utilizes microphones and accelerometers to capture acoustic signals related to blood flow turbulence
  • Employs AI and machine learning algorithms for signal processing and disease detection
  • Provides a result indicating the presence or absence of coronary artery disease
  • Test duration of approximately 10 minutes
  • Designed for use in various care settings, from community clinics to hospitals
This profile is AI-generated and may contain inaccuracies.